SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following a strong Q2 earnings report that showcased 250% year-over-year revenue growth, fueling optimism around its accelerating expansion into high-performance computing. The community is actively discussing the significant pipeline of new data center capacity and anticipated hyperscaler lease announcements, positioning APLD as a key player in the AI infrastructure sector. Despite some short-term price fluctuations attributed by many to market manipulation, a strong bullish sentiment persists for its long-term growth potential.

flyExclusive, Inc. engages in owning and operating jet aircraft for private jet passengers. It manages all aspects of the customer experience, in-house maintenance, repair, and overhaul services, including paint, interiors, and avionics capabilities. The company was founded by Thomas James Segrave, Jr. in 2015 and is headquartered in Kinston, NC.

flyExclusive Inc. - Ordinary Shares - Class A

flyExclusive is trending following news of its authorized dealership agreement with Starlink, positioning the private jet operator to install high-speed satellite internet across its fleet and for third parties. This development is sparking intense community discussion, with many actively debating its low float and the potential for a significant short squeeze. Traders are keenly observing its volatility, anticipating further price action.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX) is trending after announcing positive FDA feedback, confirming its lead asset, sonelokimab, can proceed with a BLA submission for hidradenitis suppurativa without additional clinical trials. This regulatory clarity is widely seen as a significant de-risking event, fueling strong community speculation about a potential acquisition, particularly by Merck, at a substantial premium. Investors are actively discussing the company's long-term value and the cleared path to market for its inflammatory skin disease pipeline.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

Aclarion Inc. is trending following news of significant year-over-year growth in Nociscan scan volumes, paired with a strong debt-free balance sheet and an extended cash runway. The community is actively debating the potential for a substantial short squeeze, driven by the company's tight share structure and perceived undervaluation, though some observers note its volatile history.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending after its preliminary Q4 results and future guidance projected a significant dip in DefenCath revenue due to anticipated reimbursement shifts, sparking a sharp sell-off and investor frustration. While many see the decline as an overreaction to a known temporary headwind, bullish voices emphasize compelling Real-World Evidence data for DefenCath's efficacy and the stock's deep undervaluation, noting strong institutional interest and future pipeline catalysts.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is trending with its highly engaged community actively promoting it as the next dominant multi-chain meme coin. The project highlights its deflationary burn mechanism across various bridges and strategic partnerships, fueling discussions around its organic growth. The community expresses an ambitious goal for $CAW to become the leading meme coin by surpassing established contenders like Dogecoin and Shiba Inu.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is experiencing a significant upward price movement and surging trading volume, fueling intense community debate around its near-term trajectory. Proponents emphasize its foundational utility in Japan's digital identity and IoT sector, backed by ex-Sony leadership and regulatory compliance, as indicators of a sustained breakout. Conversely, skeptics caution that the rally could be another transient event given its historical volatility and past supply dilution.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind Corp is trending following strong fourth quarter revenue guidance, highlighted by its record-setting performance, and recent FDA approval for pediatric use of its FUROSCIX On-body Infusor, alongside extended patent protection for the ReadyFlow Autoinjector. The community is actively discussing expectations for significant growth and potential M&A, particularly with partner United Therapeutics hitting new highs, though some investors express ongoing frustration with past leadership.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is experiencing heightened attention driven by a recent analyst upgrade and its strategic move to integrate advanced driving technology into more accessible electric vehicles. The community is actively weighing the company's strong overall sales performance, particularly in hybrids and trucks, against its significant pivot away from some prior electric vehicle strategies. This re-focus on profitability and a balanced product lineup is sparking both bullish sentiment for future margins and ongoing debate about market execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Musk’s White House Focus Hurting $TSLA?

Noah Loffredo

Matija Kraševec

Michael Guzman

Stocktwits

Stocktwits Polls

@StocktwitsPolls when will the retail investors understand this is how the game is played. Take your damn emotions out of it and just load up. It’s not rocket science.

Jeremiah

Nguyen To

Kevin Perez

BabyMels

S. W.

Beatrijs

Matthew Palmero

StockTwits Web

ChampagnePuts

StockTwits for iOS

 when will the retail investors understand this is how the game is played. Take your damn emotions out of it and just load up. It’s not rocket science.

ItsAlwaysGreen

@StocktwitsPolls he needs to step down and move away from any leadership role at TSLA

N.W.Clerk

Harambe91

Green s. Best

A. M. D.

Dylan Brown

Pengoon

Luke Anderson

Zistrodamus

Tres Locos

Adam

Faith Dickey

Whydoesitmatter

Lo Mill

Beta_Girl

Mart Boeuf

Lauren

RambleRon

Kramer

Gandertrades

Heidi Maher

Pags

Carsten

Aurorah

hans

Jeremy C

milt

Harman Korte

 he needs to step down and move away from any leadership role at TSLA

71Nova

@StocktwitsPolls Poorly worded poll. “Did Elon Musk coming out as a Nazi hurt Tesla?”

Dalek Time Controller

Shiggy Martin

Makuck

Dustyn Allen

Rune

Noname

Mike -O

Levii

Marc Smelik

Anne

Mathias Kalliokoski

DirkTheDaring

Mr. Mysterious

Bart404

No kids, but I got dad jokes.

no, dude.

Dustin M George

 Poorly worded poll. “Did Elon Musk coming out as a Nazi hurt Tesla?”

Cool

@StocktwitsPolls Remember...his last &quot;focus&quot; was the Cybertruck... Good or bad?  You be the judge.

Devo9er

july

Nonyabiz

Clinton

DamdD23

Dafence

John Parker Thornton

 Remember...his last "focus" was the Cybertruck... Good or bad?  You be the judge.

farmecologist

@StocktwitsPolls other reason: potential Nazi

Ok Mario

Arbuckle McShitteé

Adam18290

@StocktwitsPolls Tesla no longer needs Musk&#39;s focus.  What they need is a new CEO.

BODs, do your damn job!

StockTwits For Android 

 Tesla no longer needs Musk's focus.  What they need is a new CEO.

BODs, do your damn job!

Palmetto State

@StocktwitsPolls All the stocks have been dropping that SP500 and NASDAQ even touch the MA200!!

 All the stocks have been dropping that SP500 and NASDAQ even touch the MA200!!

NotReal_really

@StocktwitsPolls love how money is more important than fighting Nazis to some of you. #punchnazisforever

 love how money is more important than fighting Nazis to some of you. 

@StocktwitsPolls @howardlindzon would love to see a poll asking the community if $TSLA had robotaxis today to go up against waymo $goog would the community choose waymo over tsla because people don’t want to support Elon musk. Not too dissimilar to when $LYFT had a bit of an upper hand when $uber was going through some controversy. Or will price always dictate the winner?

Ron Martin

Alphabet Inc - Ordinary Shares - Class C

Lyft Inc

Uber Technologies Inc

 would love to see a poll asking the community if 

 had robotaxis today to go up against waymo 

 would the community choose waymo over tsla because people don’t want to support Elon musk. Not too dissimilar to when 

 was going through some controversy. Or will price always dictate the winner?